Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics

• by Mindong Mi, Tianhuan Xiong, Jiyong Gong, Weijie Sun, Tunguang Xu, Qifeng Jiang, Danqing Zhang, Junge Zhang, Jiancheng Huang, Wei Liang

• June 22, 2026

Early Proteomic and Metabolomic Signatures in Diabetes Associated with Progression to Diabetic Retinopathy Over 1–2 Years

• by Zhao, Jing , Cao, Yitao , Chai, Zhi , Xie, Hanghang , Gu, Dandan , Yanchun, Zhang , Dongling, Niu , Liu, Hongli , Lei, Ting

• May 29, 2026

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

• by Matthew Solan

• April 23, 2026

• 4 min

AI Screening for Diabetic Retinopathy

• by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

• May 1, 2026

• 18 min